Collab Fund logo

Collab Fund

United States$500K – $1M chequesUpdated May 2026

Invests at the pre-venture stage, applies a proprietary Villain Test to avoid future-harmful giants, features rapid small grants to de-risk climate ideas, and backs culture-shaping consumer brands. With a disciplined investment approach, the team drives value for both founders and investors.

Cheque size
$500K – $1M
Stages
Operating in
How they invest
Not specified
Technologies
Not specified

Similar investors

Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.

AgFunder logo
AgFunder
United States
85% match

Is dedicated to impactful businesses aiming to positively transform the world's food system.

  • Invests at Series A
  • Technology · Healthcare
  • Active in United States
Series AAgricultureHealthcare
$10K – $5M
At One Ventures logo
At One Ventures
United States
80% match

Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.

  • Invests at Series A
  • Technology · Healthcare
  • Active in United States
Series AEnergyAgriculture
$100K – $5M
Canaan Partners logo
Canaan Partners
United States
80% match

Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.

  • Invests at Series A
  • Technology · Healthcare
  • Active in United States
Series AFinanceHealthcare
$1M – $20M
Able Partners logo
Able Partners
United States
75% match

Women-led VC systematically backs clinically rigorous, behaviorally grounded wellbeing nascent-stage companies tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX. With a disciplined investment approach, the team drives value for both founders and investors.

  • Invests at Series A
  • Healthcare · Agriculture
  • Active in United States
Series AAgricultureRetail
$500K – $3M
AV8 Ventures logo
AV8 Ventures
United States
75% match

Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.

  • Invests at Series A
  • Technology · Healthcare
  • Active in United States
Series AFinanceHealthcare
$500K – $10M
BoxOne Ventures logo
BoxOne Ventures
Canada
75% match

Invests from napkin-stage through IPO using an evergreen own-capital model for patient, flexible long-term support; active nascent-stage investor (~180 deals) oriented toward deep bio and frontier software/crypto. With a disciplined investment approach, the team drives value for both founders and investors.

  • Invests at Series A
  • Technology · Healthcare
  • Similar cheque size
Series AHealthcareFinance
$500K – $500K